Naltrexone. Naltrexone is taken once a day or three times a week as a pill or as a once-a-month injection called Vivitrol. Although it can have some side effects, they tend to be mild and are rarely dangerous. Naltrexone can be prescribed by any physician or trained medical provider and does not require a special clinic or program. It can reduce cravings for opioids and blocks the effects of opioids on the brain, which can stop a person from getting “high.” However, it does not reduce withdrawal symptoms. You must first stop taking all opioids for at least 7 to 10 days before you can start taking naltrexone or you will experience severe withdrawal discomfort. You should not take naltrexone if you are taking lawfully prescribed opioid medication for pain or other medical problems. Your doctor or medical provider will talk with you about whether naltrexone or Vivitrol may be the right medication for you. Preventing or Reversing Overdose You should also know about another medicine called naloxone or Narcan. Narcan is not used to treat opioid use disorders but is used in case of an emergency to stop an overdose on opioids. It can be given as a shot by trained professionals or squirted into the nose by people without medical training who have been shown how to use it. Most cities or states have laws allowing people to keep naloxone with them and use it in case of an emergency. Check with the treatment court or your treatment provider about receiving training in using naloxone and getting a naloxone kit. [OPTIONAL IF APPLICABLE: The Treatment Court offers training in how to use Narcan to save another person’s life and provides free kits that you and your loved ones can keep with you and use in the event of a life-threatening overdose emergency.] Can I Take MOUD While Enrolled in Treatment Court? The Treatment Court is committed to providing safe and effective treatments for opioid use disorders while also protecting your welfare, the welfare of other participants, and public safety. Therefore, you are allowed to take MOUD when it is approved by the treatment court team and prescribed legally by a physician or other medical provider who has personally examined you and will continue to meet with you to see how you are doing. Whether or not you take MOUD, you will receive all of the same treatment and other services as other people in the program and will get the same benefits from graduating. Choosing whether or not to use MOUD, which medication to use, and the safest and bes...
Naltrexone. For the treatment of alcohol use disorder AND in combination with behavioural intervention therapy (i.e., psychosocial counselling) as necessary. Approval period: 3 months Acamprosate: For the maintenance of abstinence in patients who have been abstinent from alcohol for at least four days OR for the treatment of alcohol use disorder for patients who have contraindications to naltrexone (i.e., concurrent opioid use, acute hepatitis, or liver failure) AND in combination with behavioural intervention therapy (i.e., psychosocial counselling) as necessary. Approval period: 3 months Terms of the Agreement: PSD reserves the right to: Implement Collaborative Prescribing Agreements for PharmaCare coverage; require renewals of such Agreements; and, as necessary, conduct quality assurance checks of such processes. For quality assurance purposes, the physician with a valid exemption agrees to receive feedback on his/ her prescribing of naltrexone or acamprosate, such as de-personalized, aggregate prescribing data. Patients whose prescriptions for naltrexone or acamprosate are written by a prescriber who has entered into a Collaborative Prescribing Agreement will receive automatic coverage for their subsequent claim. PharmaCare coverage is not retroactive. A current valid Agreement must be in place before a patient fills a prescription. PharmaCare coverage for naltrexone or acamprosate is only available with a valid Collaborative Prescribing Agreement. For any patient who does not meet the terms of this Agreement, a prescriber who has entered into a Collaborative Prescribing Agreement must write the following instruction to pharmacists on the prescription “Submit as zero cost to PharmaCare,” indicating that these prescriptions are not to be covered by PharmaCare. A physician’s exemption may be discontinued if the exempted physician prescribes naltrexone or acamprosate in a manner inconsistent with the terms of this Agreement. Name of prescriber (please print) College of Physicians & Surgeons ID Number Prescriber signature Medical Services Plan Billing Number Date submitted Fax # (to which confirmation of exemption should be sent) FAX COMPLETED AGREEMENT TO HEALTH INSURANCE BC at 0-000-000-0000 A copy of this Agreement will be kept on file at the Ministry of Health. PSD Use Only:
Naltrexone. Naltrexone, its physiologically active salts, derivatives, precursors or other chemical form of naltrexone which provides the physiological activity of naltrexone. THE PROJECT
Naltrexone. Please complete the following details: Patient’s name, address, date of birth Consultant’s contact details (p.3) And send One copy to:
